Duality Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,197
| Closed | -$1.67M | – | 23 |
|
|
2024
Q1 | $1.67M | Sell |
11,197
-5,915
| -35% | -$884K | 0.17% | 218 |
|
|
2023
Q4 | $3.28M | Buy |
17,112
+7,682
| +81% | +$1.47M | 0.35% | 84 |
|
|
2023
Q3 | $1.67M | Buy |
9,430
+5,697
| +153% | +$1.01M | 0.2% | 183 |
|
|
2023
Q2 | $709K | Buy |
3,733
+1,682
| +82% | +$319K | 0.09% | 341 |
|
|
2023
Q1 | $411K | Buy |
+2,051
| New | +$411K | 0.05% | 444 |
|
|
2022
Q4 | – | Sell |
-16,926
| Closed | -$3.39M | – | 571 |
|
|
2022
Q3 | $3.39M | Buy |
16,926
+13,274
| +363% | +$2.66M | 0.37% | 77 |
|
|
2022
Q2 | $533K | Sell |
3,652
-1,819
| -33% | -$265K | 0.05% | 455 |
|
|
2022
Q1 | $893K | Sell |
5,471
-6,702
| -55% | -$1.09M | 0.1% | 352 |
|
|
2021
Q4 | $2.06M | Sell |
12,173
-4,631
| -28% | -$785K | 0.22% | 174 |
|
|
2021
Q3 | $3.17M | Buy |
+16,804
| New | +$3.17M | 0.24% | 164 |
|
|
2021
Q2 | – | Sell |
-12,039
| Closed | -$1.7M | – | 521 |
|
|
2021
Q1 | $1.7M | Sell |
12,039
-4,981
| -29% | -$703K | 0.15% | 249 |
|
|
2020
Q4 | $2.21M | Buy |
+17,020
| New | +$2.21M | 0.16% | 189 |
|